(lp0
S"The Investment Analysts' Recent Ratings Updates for TearLab Corp  Petro Global News 24 - 16 hours ago TearLab Corp  opened at 3.18 on Tuesday. TearLab Corp has a one year low of $2.95 and a one year high of $9.10.TearLab Corp  Upgraded at Zacks Investment Research - Community Financial NewsAnalysts Take the Wheel on TearLab Corporation  Shares and Where ... - Aiken Advocate"
p1
aS'Why TearLab Corp. Shares Dipped Motley Fool - Nov 13, 2013 What: Shares of TearLab , an ophthalmic  medical device company focused on helping diagnose dry eye disease, dipped as much as 11% after the company reported its third-quarter earnings results.'
p2
aS"TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ... GlobeNewswire  - Nov 7, 2016 SAN DIEGO, Nov. 07, 2016  -- TearLab Corporation    today reported its consolidated financial results for the third quarter and nine months ended September 30, 2016.TearLab's  CEO Seph Jensen on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha"
p3
aS'Crunching the Numbers for TearLab Corp  Baxter Review - 13 hours ago Investors and Traders using technical analysis to study stocks may be looking at the ATR or Average True Range. Presently, TearLab Corp  has a 14-day ATR of 0.46. The Average True Range is an investor tool used to gauge stock volatility. The ATR&nbsp;...'
p4
aS'Analyst Activity  Rodman &amp; Renshaw Raises Its Price Target On TearLab Corp ... Market Exclusive - Mar 10, 2017 Today, Rodman &amp; Renshaw raised its price target on TearLab Corp  to per share. There are 1 hold rating, 2 buy ratings, 1 strong buy rating on the stock.TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results - Yahoo FinanceTearLab Corp  Releases Earnings Results, Beats Expectations By $0.09 EPS - Chaffey Breeze'
p5
aS'TearLab Corp. MarketWatch - Dec 21, 2009 TearLab Corp. NASDAQ: TEAR. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p6
aS'TearLab Corp  Stock Rating Upgraded by Zacks Investment Research Chaffey Breeze - Mar 20, 2017 TearLab Corp logo TearLab Corp  was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report released on Thursday.The The Rodman &amp; Renshaw Reaffirms Buy Rating for TearLab Corp  - Petro Global News 24TearLab Corporation  Reviewed By Analysts - The De Soto Edge'
p7
aS'TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ... GlobeNewswire  - Jul 12, 2016 SAN DIEGO, July 12, 2016  -- TearLab Corporation   , a company that develops and markets point of care ophthalmic in-vitro diagnostics, today recognized Shire plc on its recent&nbsp;...'
p8
aS"Why This Analyst Sees TearLab Shares Tripling Benzinga - Jul 12, 2016 Rodman &amp; Renshaw's Raghuram Selvaraju mentioned that TearLab Corp 's Osmolarity System for the diagnosis of dry eye disease  is the first and only objective DED diagnostic test in the U.S."
p9
aS"The FDA Confirms The Approval of Xiidra From TearLab Corp  Journal Transcript - Jul 15, 2016 The US Food and Drug Administration  has penned an approval of Xiidra from TearLab Corp . The FDA's action presents more options to patients suffering from dry eye disease."
p10
a.